Skip to content

Clinical trials

Phase 1 Myelodysplastic Syndromes trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1 Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20141
20152
20174
20181
20202
20212
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Active, not recruiting2
Recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AbbVie3
Institut de Recherches Internationales Servier2
Amgen1
Beijing InnoCare Pharma Tech Co., Ltd.1
Bristol-Myers Squibb1
Children's Oncology Group1
Cleave Therapeutics, Inc.1
Clinical Hub for Interventional Research (CHOIR)1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes20
Leukemia, Myeloid, Acute17
Leukemia4
Leukemia, Myelomonocytic, Chronic4
Lymphoma, Non-Hodgkin3
Multiple Myeloma3
Leukemia, Lymphocytic, Chronic, B-Cell2
Neoplasms2
Recurrence2
Astrocytoma1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.